Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

3,4,5-Trihydroxycinnamic acid decyl ester

3,4,5-Trihydroxycinnamic acid decyl ester
Contact us for more batch information
Select Batch
Resource Download

3,4,5-Trihydroxycinnamic acid decyl ester

Catalog No. T39189Cas No. 1770778-45-4
3,4,5-Trihydroxycinnamic acid decyl ester is a pancreatic lipase inhibitor with anticancer activity that induces apoptosis.3,4,5-Trihydroxycinnamic acid decyl ester has anti-obesity effects, inhibits lipid uptake and accumulation, and is used in studies of breast and prostate cancer.3,4,5-Trihydroxycinnamic acid decyl ester has anti-obesity effects, inhibits lipid uptake and accumulation, and is used in studies of breast and prostate cancer. It can be used to study breast cancer and prostate cancer.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$75In Stock
Bulk & Custom
Add to Cart
Questions
View More

Product Introduction

Bioactivity
Description
3,4,5-Trihydroxycinnamic acid decyl ester is a pancreatic lipase inhibitor with anticancer activity that induces apoptosis.3,4,5-Trihydroxycinnamic acid decyl ester has anti-obesity effects, inhibits lipid uptake and accumulation, and is used in studies of breast and prostate cancer.3,4,5-Trihydroxycinnamic acid decyl ester has anti-obesity effects, inhibits lipid uptake and accumulation, and is used in studies of breast and prostate cancer. It can be used to study breast cancer and prostate cancer.
In vitro
3,4,5-Trihydroxycinnamic acid decyl ester inhibits pancreatic lipase activity in a dose-dependent manner, with an EC50 value of 0.9 μM [1].
In vivo
In 6-week-old male ddY mice, 3,4,5-Trihydroxycinnamic acid decyl ester (30 mg/kg, 150 mg/kg; oral administration) reduces plasma triglyceride levels in a dose-dependent manner[1].
Chemical Properties
Molecular Weight336.42
FormulaC19H28O5
Cas No.1770778-45-4
Storage & Solubility Information
Storagestore at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 80 mg/mL (237.80 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9725 mL14.8624 mL29.7247 mL148.6237 mL
5 mM0.5945 mL2.9725 mL5.9449 mL29.7247 mL
10 mM0.2972 mL1.4862 mL2.9725 mL14.8624 mL
20 mM0.1486 mL0.7431 mL1.4862 mL7.4312 mL
50 mM0.0594 mL0.2972 mL0.5945 mL2.9725 mL
100 mM0.0297 mL0.1486 mL0.2972 mL1.4862 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords